MCID: SCH014
MIFTS: 58

Schistosomiasis malady

Categories: Rare diseases, Infectious diseases, Blood diseases

Aliases & Classifications for Schistosomiasis

About this section

Summaries for Schistosomiasis

About this section
CDC:2 Schistosomiasis, also known as bilharzia, is a disease caused by parasitic worms. Although the worms that cause schistosomiasis are not found in the United States, more than 200 million people are infected worldwide. In terms of impact this disease is second only to malaria as the most devastating parasitic disease. Schistosomiasis is considered one of the Neglected Tropical Diseases (NTDs).

MalaCards based summary: Schistosomiasis, also known as katayama fever, is related to abdominal tuberculosis and hepatic coma, and has symptoms including schistosomal pigment deposition An important gene associated with Schistosomiasis is IL4 (Interleukin 4), and among its related pathways are African trypanosomiasis and Cellular Transformation by HTLV1. The drugs praziquantel and oxamniquine have been mentioned in the context of this disorder. Affiliated tissues include liver, testes and kidney, and related mouse phenotypes are integument and respiratory system.

Disease Ontology:11 A parasitic helminthiasis infectious disease that involves infection of the intestine, urinary tract, skin, liver and spleen caused by multiple species of the trematode fluke of the genus Schistosoma. The symptoms include fever, chills, nausea, abdominal pain, diarrhea, malaise, myalgia, liver and spleen enlargement, rash and hematuria.

Wikipedia:70 Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms... more...

Related Diseases for Schistosomiasis

About this section

Diseases related to Schistosomiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 494)
idRelated DiseaseScoreTop Affiliating Genes
1abdominal tuberculosis30.0CD40LG, IL13, IL4
2hepatic coma29.8ALB, F2, TNF
3alcohol abuse29.7F2, IL10, TNF
4retroperitoneal fibrosis29.7CD40LG, IL10, TGFB1, TNF
5vaginitis29.4CD79A, IL10, IL13, IL4, IL5, RNASE3
6collagen disease29.2IFNG, IL10, IL2
7bacteriuria28.8CD40LG, IFNG, IL10, IL2, IL4, TNF
8asthma27.5CD40LG, CD79A, IFNG, IGHE, IL10, IL13
9malaria27.4ALB, CD40LG, IFNG, IFNGR1, IL10, IL13
10intestinal schistosomiasis12.4
11urinary schistosomiasis12.3
12cercarial dermatitis11.8
13schistosoma mansoni infection, susceptibility/11.3
14neuroschistosomiasis10.9
15gosr2-related progressive myoclonus ataxia10.8CD40LG, IGHE
16cytoplasmic body myopathy10.7IL13, IL5
17piepkorn karp hickok syndrome10.7IL10, TNF
18myoclonus epilepsy10.7IFNG, IL4
19calcific tendinitis10.7CD40LG, CD79A
20medullary sponge kidney10.7CD40LG, CD79A
21balkan hemorrhagic fever10.7CD40LG, IL10
22exfoliative dermatitis10.7CD79A, IGHE
23variola major10.7CD40LG, CD79A
24indian tick typhus10.7CD40LG, IFNG, IL13
25mu chain disease10.7CD40LG, CD79A
26gastroschisis abdominal wall defects, included10.7IFNG, IL5
27retinal cancer10.7CD40LG, CD79A
28cherry allergy10.7IL10, IL13, IL5
29focal embolic glomerulonephritis10.7CD40LG, CD79A
30toxic diffuse goiter10.7IL13, IL5, RNASE3
31aortic arch interruption10.6IL13, IL5, TNF
32baetz-greenwalt syndrome10.6IFNG, IGHE, TNF
33polyradiculoneuropathy10.6IL10, IL13, IL5
34heart disease10.6CD40LG, CD79A
35orbit alveolar rhabdomyosarcoma10.6IFNG, IL10, IL13
36epididymis adenocarcinoma10.6IL13, IL4, IL5
37glucose intolerance10.6IL13, IL4, IL5
38bacterial gastritis10.6IL13, IL4, IL5
39idiopathic neutropenia10.6IFNG, IL10, IL5
40endometrial stromal nodule10.6CD40LG, CD79A, IFNG
41plantar nerve lesion10.6IL13, RNASE3, TNF
42adenomatoid tumor10.6IL13, IL4, IL5
43eye accommodation disease10.6IFNG, IL10, IL4
44van benthem-driessen-hanveld syndrome10.6CD40LG, CD79A
45keratoconjunctivitis10.6IL4, IL5, RNASE3
46cervix melanoma10.6IFNG, IL4, IL5
47chronic pulmonary heart disease10.6IL4, IL5, RNASE3
48african histoplasmosis10.6CD40LG, IL4, IL5
49thelaziasis10.6IFNG, IL10, IL4
50papillary cystadenocarcinoma10.6IL10, IL13, TGFB1

Graphical network of the top 20 diseases related to Schistosomiasis:



Diseases related to schistosomiasis

Symptoms for Schistosomiasis

About this section

UMLS symptoms related to Schistosomiasis:


schistosomal pigment deposition

Drugs & Therapeutics for Schistosomiasis

About this section

Drugs for Schistosomiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 75)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
LumefantrineapprovedPhase 414582186-77-46437380
Synonyms:
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha-((dibutylamino)methyl)fluorene-4-methanol
(±)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol
120583-69-9
2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl]ethanol
2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol
2-Dibutylamino-1-[2,7-dichloro-9-(4-chloro-benzylidene)-9H-fluoren-4-yl]-ethanol
2-Dibutylamino-1-{2,7-dichloro-9-[1-(4-chloro-phenyl)-meth-(Z)-ylidene]-9H-fluoren-4-yl}-ethanol
82186-77-4
AC-4542
AC1O5NKD
Benflumetol
Bio-0132
C30H32Cl3NO
 
CHEBI:156095
CHEMBL38827
CID6437380
Coartem
D03821
DB06708
HSDB 7210
I14-7746
LS-177674
Lumefantrine
Lumefantrine (INN)
Lumefantrine [INN:BAN]
MolPort-006-394-826
NCGC00167490-01
UNII-F38R0JR742
dl-Benflumelol
2
ArtemetherapprovedPhase 414571963-77-4119380, 68911
Synonyms:
( )-alpha-Artemether
(1R,4S,5R,8S,9R,10S,12R,13R)-10-Methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepine
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin
(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12beta,12aR*)-isomer of artemether
(3r,5as,6r,8as,9r,10r,12r,12ar)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene
(5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene
.beta.-Artemether
.beta.-Dihydroartemisinin methyl ether
.beta.-Methylether of 11-epi-dihydroartemisinin
10-Methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
10-methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
159573-83-8
3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-tri
71939-51-0
71963-77-4
74784-06-8
80286-56-2
93787-85-0
AC1L2APD
AC1L2XO8
AC1L9SH2
AC1L9UV0
AC1MI2ZX
AC1Q6Z74
AC1Q6Z7V
AR-1A4424
Arteannuin ether
Artemetero
Artemetero [INN-Spanish]
Artemether
Artemether (INN)
Artemether [INN]
Artemetheri
Artemetherum
Artemetherum [INN-Latin]
Artemisininelactol methyl ether
Artemos
Artenam
Artesaph
Artesian
Artimist
Artmether
BRN 5948416
C16H26O5
CHEBI:195280
 
CHEMBL411864
CHEMBL512315
CID10266705
CID104888
CID3062122
CID456408
CID500199
CID6483308
CID6712286
CID68911
CID9796294
CID9796295
CPD000469218
D02483
DB06697
Dihydroartemisinin methyl ether
Dihydroqinghaosu methyl ether
Dihydroquinghaosu methyl ether
Falcidol
Gvither
HMS2052L09
HSDB 7456
I06-0205
KST-1A8041
LS-176935
LS-64237
MLS001424249
Malartem
Methyl-dihydroartemisinine
NCI60_022891
NSC 665970
NSC665970
O-Methyldihydroartemisinine
Paluther
S2264_Selleck
SAM001246799
SM 224
SM 229
SM-224
SMR000469218
UNII-C7D6T3H22J
alpha-Artemether
alpha-Dihydroartemisinin methyl ether
artemether, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12aR*))-isomer
artemether[inn]
beta-Artemether
beta-Dihydroartemisinin methyl ether
rither
3
Miconazoleapproved, investigational, vet_approvedPhase 4362422916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
4
Praziquantelapproved, vet_approvedPhase 4, Phase 3, Phase 2, Phase 13755268-74-14891
Synonyms:
(.+-)-2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1a)isoquinolin-4-one
(11bS)-2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
135526-78-2
2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro- 4H-pyrazino[2,1-a]-isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a)isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7-11b-hexahydro-4H-pyrazino(2,1a)isoquinolin-4-one
2-(Cyclohexylcarbonyl)-1,2,3,6,7-11b-hexahydro-4H-pyrazinoe(2,1a)isoquinolin-4-one
2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one
2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinolin-4-one
2-Cyclohexanecarbonyl-1,2,3,6,7,11b-hexahydro-pyrazino[2,1-a]isoquinolin-4-one
2-Cyclohexylcarbonyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino(2,1-a) isoquinolin-4-one
46648_FLUKA
46648_RIEDEL
5-24-03-00361 (Beilstein Handbook Reference)
55268-74-1
57452-31-0
8440, EMBAY
AB00052075
AC-11670
AC1L1J6N
AKOS000541869
Azinox
BAS 00347357
BPBio1_000088
BRD-A21858158-001-05-2
BRN 0761557
BSPBio_000080
BSPBio_002199
Bay-8440
Bayer Brand of Praziquantel
Biliricide
Biltricide
Biltricide (TN)
Biltricide, Droncit, Praziquantel
Bio-0456
C07367
CCRIS 4114
CHEMBL976
CID4891
CPD000037139
Cesol
Cisticid
Cutter
Cutter Tape Tabs
Cysticide
D00471
D011223
DB01058
DivK1c_000130
Droncit
Drontsit
EINECS 259-559-6
EINECS 260-741-2
EMBAY-8440
EU-0100909
Embay 8440
HMS1568D22
HMS1920J06
HMS2090J19
 
HMS2092A09
HMS500G12
I06-0088
IDI1_000130
InChI=1/C19H24N2O2/c22-18-13-20(19(23)15-7-2-1-3-8-15)12-17-16-9-5-4-6-14(16)10-11-21(17)18/h4-6,9,15,17H,1-3,7-8,10-13H
KBio1_000130
KBio2_001599
KBio2_004167
KBio2_006735
KBio3_001699
KBioGR_000963
KBioSS_001599
LS-23174
LS-7155
Lopac0_000909
MLS000028528
MLS000038419
MLS001201812
MLS001304085
Merck Brand of Praziquantel
MolPort-001-926-470
NCGC00015818-05
NCGC00015818-11
NCGC00089733-02
NCGC00089733-03
NCGC00089733-04
NCGC00089733-05
NINDS_000130
NPFAPI-02
Oprea1_163497
P 4668
P4668_SIGMA
Prasiquantel
Praziquantel (JAN/USP/INN)
Praziquantel [USAN:INN:BAN:JAN]
Praziquantel, (+-)-Isomer
Praziquantel, (R)-Isomer
Praziquantel, (S)-Isomer
Praziquantelum
Praziquantelum [INN-Latin]
Prestwick0_000260
Prestwick1_000260
Prestwick2_000260
Prestwick3_000260
Prestwick_402
Pyquiton
S1691_Selleck
SAM002264632
SMR000037139
SPBio_001295
SPBio_002299
SPECTRUM1500494
STK030186
Spectrum2_001288
Spectrum3_000550
Spectrum4_000482
Spectrum5_001064
Spectrum_001119
Traziquantel
UNII-6490C9U457
praziquantel
5
Albendazoleapproved, vet_approvedPhase 4, Phase 38054965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
6Artemether-lumefantrine combinationPhase 4138
7ArtemisininePhase 4, Phase 2, Phase 3286
8ArtemisininsPhase 4, Phase 2, Phase 3286
9Antifungal AgentsPhase 43615
10Antiprotozoal AgentsPhase 4, Phase 2, Phase 31986
11AnthelminticsPhase 4, Phase 3, Phase 2, Phase 1431
12AntimalarialsPhase 4, Phase 2, Phase 31216
13Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 121402
14Antiparasitic AgentsPhase 4, Phase 3, Phase 2, Phase 12127
15Antimitotic AgentsPhase 4, Phase 35498
16
SulfadoxineapprovedPhase 3, Phase 21282447-57-617134
Synonyms:
2447-57-6
4-Amino-N-(5,6-dimethoxy-4-pyrimidinyl)benzenesulfonamide
4-Sulfanilamido-5,6-dimethoxypyrimidine
4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide
4-amino-N-[5,6-bis(methyloxy)pyrimidin-4-yl]benzenesulfonamide
46810_RIEDEL
5-25-13-00306 (Beilstein Handbook Reference)
6-(4-Aminobenzenesulfonamido)-4,5-dimethoxypyrimidine
AB00514044
AC-11921
AC1L29DT
AC1Q46GG
Ambap2447-57-6
BPBio1_001286
BRD-K55250441-001-03-1
BRN 0625453
BSPBio_001168
C07630
CAS-2447-57-6
CHEBI:9329
CHEMBL1539
CID17134
D00580
DB01299
EINECS 219-504-9
Fanasil
Fanzil
HMS1571K10
HMS2090P07
HMS2094C19
I09-0529
LS-31247
MLS002154150
MolPort-003-850-341
N'-(5,6-Dimethoxy-4-pyrimidyl)sulfanilamide
N(sup 1)-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
 
N1-(5,6-Dimethoxy-4-pyrimidinyl)sulfanilamide
NCGC00016612-01
NCGC00016612-02
Orthosulfin
Prestwick0_001094
Prestwick1_001094
Prestwick2_001094
Prestwick3_001094
Ro 4-4393
Ro-4-4393
S2511_Selleck
S7821_SIGMA
SMR000857259
SPBio_003054
SULFADOXINE
Sanasil: Sulfadoxine: Sulformetoxin
Solfadossina
Solfadossina [DCIT]
Sulfadoxin
Sulfadoxina
Sulfadoxina [INN-Spanish]
Sulfadoxine
Sulfadoxine (JAN/USP/INN)
Sulfadoxine [USAN:INN:BAN:JAN]
Sulfadoxinum
Sulfadoxinum [INN-Latin]
Sulformethoxine
Sulformetoxine
Sulforthomidine
Sulphadoxine
Sulphormethoxine
Sulphormetoxin
Sulphorthodimethoxine
UNII-88463U4SM5
WR 4073
WR 4873
ZINC00002094
17
ArtesunateapprovedPhase 2, Phase 318188495-63-06917864, 5464098
Synonyms:
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-ol, hydrogen succinate
112346-66-4
182824-33-5
252637-87-9
4-Oxo-4-(((3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10-yl hydrogen butanedioate
4-oxo-4-{[(3r,5as,6r,8as,9r,10r,12r,12ar)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid
4-oxo-4-{[(5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid
83507-69-1
88495-63-0
91487-94-4
AC1L23PW
AC1L2XWW
AC1L4FU0
AC1Q5VRV
AKOS004119951
AS
Ambap88495-63-0
Arinate
Arsumax
Arsumax (TN)
Artesunate
Artesunate (USAN)
Artesunate (superseded RN)
Artesunato
Artesunato [INN-Spanish]
Artesunatum
Artesunatum [INN-Latin]
Artesunic acid
Artsuna
BB_NC-1045
Butanedioic acid, mono((3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester
Butanedioic acid, mono(decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester
C19H28O8
CHEMBL218601
CHEMBL258608
CID105031
CID11520210
CID11988384
CID156252
 
CID5464098
CID65664
CID6917864
CID9821433
CPD000466336
D02482
Dihydroartemisinine-12-alpha-succinate
Dihydroqinghaosusuccinate
Dihydroqinghasu hemsuccinate
FT-0082543
HMS2051I14
HMS2090L16
HSDB 7458
I06-0204
LS-177760
LS-187735
MLS000759445
MLS001424053
MolPort-001-732-325
MolPort-006-392-384
NCI60_039350
NSC712571
Nuartez
Plasmotrim
Plasmotrin
Qinghaozhi
Quinghaosu reduced succinate ester
S2265_Selleck
SAM001246628
SM 804
SMR000466336
STK801911
Succinyl dihydroartemisinin
UNII-60W3249T9M
WR 256283
WR-256283
artesunato
artesunatum
artesunic acid
butanedioic acid, 1-[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl] ester
dihydroqinghasu hemsuccinate
18
Pyrimethamineapproved, vet_approvedPhase 2, Phase 315258-14-04993
Synonyms:
2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(P-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine
2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine
46706_FLUKA
46706_RIEDEL
4753 R.P.
4753 r.p
5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE
5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE
5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidi nediamine
5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine
5-(4-chlorophenyl)-2,4-diamino-6-ethylpyrimidine
5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine
5-(p-chlorophenyl)-6-ethyl-2,4-diaminopyrimidine
5-[4-Chlorophenyl]-6-ethyl-2,4-pyrimidinediamine
58-14-0
AB00052084
AC-7879
AC1L1JDI
AI3-25005
AZT + Pyrimethamine combination
Aventis Brand of Pyrimethamine
BIDD:GT0149
BIDD:PXR0173
BPBio1_000147
BRD-K88429204-001-05-4
BRN 0219864
BSPBio_000133
BSPBio_003282
BW 50-63
BW 5063
C07391
C12H13ClN4
CAS-58-14-0
CCRIS 546
CD
CHEBI:8673
CHEMBL36
CID4993
CP6
CPD000058714
CRL-8131 & Pyrimethamine
CRL-8142 & Pyrimethamine
Chloridin
Chloridine
Chloridyn
D00488
D011739
DB00205
Darachlor
Daraclor
Darapram
Daraprim
Daraprim (TN)
Daraprime
Daraprin
Diaminopyritamin
Disulone
DivK1c_000652
EINECS 200-364-2
EXR-101
Erbaprelina
Ethylpyrimidine
Fansidar
Fansidar (Pyrimethamine/Sulfadoxine)
Glaxo Wellcome Brand of Pyrimethamine
GlaxoSmithKline Brand of Pyrimethamine
HMS1568G15
HMS1920N12
HMS2092E13
HMS502A14
IDI1_000652
KBio1_000652
KBio2_001386
KBio2_003954
 
KBio2_006522
KBio3_002502
KBioGR_001007
KBioSS_001386
Khloridin
L000713
LS-238
Lactoferrin B & Pyrimethamine
Lactoferrin H & Pyrimethamine
MCB-3837
MLS000028606
MLS001148621
MLS002454446
MLS002701881
Malacid
Malocid
Malocide
Maloprim
MolPort-001-783-655
NCGC00016256-01
NCGC00016256-02
NCGC00023188-03
NCGC00023188-04
NCGC00023188-05
NCGC00023188-06
NCGC00023188-07
NCI-C01683
NCI60_002604
NCIOpen2_008313
NINDS_000652
NSC 3061
NSC-3061
NSC3061
Oxaquin
Pirimecidan
Pirimetamin
Pirimetamina
Pirimetamina [INN-Spanish]
Pirimetamina [Spanish]
Prestwick0_000037
Prestwick1_000037
Prestwick2_000037
Prestwick3_000037
Prestwick_504
Primethamine
Pyremethamine
Pyrimethamin
Pyrimethamine (JAN/USP/INN)
Pyrimethamine (Pyr)
Pyrimethamine Hcl
Pyrimethamine [USAN:INN:BAN:JAN]
Pyrimethaminum
Pyrimethaminum [INN-Latin]
RP 4753
S2006_Selleck
SAM002554921
SMR000058714
SPBio_000672
SPBio_002054
SPECTRUM1500520
Spectrum2_000886
Spectrum3_001701
Spectrum4_000494
Spectrum5_001447
Spectrum_000906
TCMDC-123831
TCMDC-125860
Tindurin
Tindurine
Tinduring
UNII-Z3614QOX8W
WLN: T6N CNJ BZ DZ ER DG& F2
WR 2978
Wellcome Brand of Pyrimethamine
ZINC00057464
m alocid
nchembio.215-comp13
nchembio.87-comp22
pyrimethamine
19
IronapprovedPhase 311237439-89-623925
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
ATW 230
ATW 432
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
C00023
C3518_SIAL
C3518_SIGMA
CCRIS 1580
CHEBI:18248
CID23925
Carbonyl iron
Copy Powder CS 105-175
D007501
DB01592
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Diseases (animal), iron overload
Diseases, iron overload
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
 
Ed-In-Sol
Eisen
Electrolytic iron
F 60 (metal)
FE
FT 3 (element)
Fe
Fe-40
Fe1+
Feronate
Ferretts
Ferro-Caps
Ferro-Time
Ferrousal
Ferrovac E
Ferrum
Ferrum metallicum
GS 6
HF 2 (element)
HL (iron)
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Hemocyte
Hierro
Hoeganaes ATW 230
Hoeganaes EH
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron powder
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(III) nitrate solution
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
Iron, reduced
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh-1M3
PZh-2
PZh1M1
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Reduced iron
Remko
SUY-B 2
Siderol
UNII-E1UOL152H7
Vitedyn-Slo
Yieronia
fer
ferrous iron
hierro
20
Tranexamic AcidapprovedPhase 32571197-18-85526
Synonyms:
08455_FLUKA
1197-17-7
1197-18-8
1ceb
3-14-00-00868 (Beilstein Handbook Reference)
4-(Aminomethyl)-Cyclohexanecarboxylic Acid
4-(Aminomethyl)cyclohexanecarboxylic acid
4-(aminomethyl)cyclohexane-1-carboxylic acid
857653_ALDRICH
A0236
AB00052260
AB1003647
AC-4687
AC1L1KJH
AC1Q50F3
AC1Q546D
AC1Q5U04
ALBB-006013
AMCA
AMCHA
AMH
AR-1F6595
Acide tranexamique
Acide tranexamique [INN-French]
Acido tranexamico
Acido tranexamico [INN-Spanish]
Acidum tranexamicum
Acidum tranexamicum [INN-Latin]
Amikapron
Amstat
Anvitoff
BAY 3517
BPBio1_000069
BRN 2207452
BSPBio_000061
BSPBio_002837
CAS-1197-18-8
CHEBI:48669
CHEMBL292500
CHEMBL877
CID5526
CL 65336
CL-65336
Carxamin
Cyclocapron
Cyklokapron
Cyklokapron (TN)
D01136
DB00302
DV 79
DV-79
DV79
DivK1c_000655
EINECS 214-818-2
Emorhalt
Exacyl
Frenolyse
HMS1568D03
HMS1921F08
HMS2092P03
HMS502A17
Hexapromin
Hexatron
I04-0993
IDI1_000655
KABI 2161
KBio1_000655
KBio2_001871
KBio2_004439
KBio2_007007
KBio3_002337
KBioGR_000511
 
KBioSS_001871
LS-56611
LS-56612
LT00159441
Mastop
MolPort-001-792-390
MolPort-002-512-008
NCGC00016569-01
NCGC00016569-02
NCGC00016569-03
NCGC00094944-01
NCGC00094944-02
NINDS_000655
NSC 291305
NSC291305
Oprea1_786414
Prestwick0_000171
Prestwick1_000171
Prestwick2_000171
Prestwick3_000171
Prestwick_476
RP 18,429
Rikavarin
Rikavarin (TN)
Rikavarin-S
SPBio_000689
SPBio_001982
SPECTRUM1502026
STK503668
STOCK1N-16183
Spectrum2_000655
Spectrum3_001189
Spectrum4_000046
Spectrum5_001258
Spectrum_001391
Spiramin
Tamcha
Tranex
Tranexamate
Tranexamic acid (JP15/USAN/INN)
Tranexamic acid [USAN:INN:BAN:JAN]
Tranexamic acid cis-form
Tranexamsaeure
Tranexan
Tranexmic acid
Tranhexamic acid
Trans AMCHA
Trans-1-(Aminomethyl)cyclohexane-4-carboxylic acid
Trans-4-(Aminomethyl)-1-cyclohexanecarboxylic acid
Trans-p-(Aminomethyl)cyclohexanecarboxylic
Transamin
Transamin (TN)
Transamlon
Trasamlon
UNII-6T84R30KC1
Ugurol
WLN: L6TJ AVQ D1Z -T
cis-4-(Aminomethyl)cyclohexanecarboxylic acid
cis-4-Aminomethylcyclohexane-1-carboxylic acid
cis-AMCHA
t-AMCHA
tranexamic acid
tranexmic acid
trans-1-Aminomethylcyclohexane-4-carboxylic acid
trans-4-(Aminomethyl)cyclohexane-1-carboxylic acid
trans-4-(Aminomethyl)cyclohexane-carboxylic acid
trans-4-(Aminomethyl)cyclohexanecarboxylic acid
trans-4-(Aminomethyl)cyclohexanecarboxylic acid ester
trans-4-Aminomethylcyclohexane-1-carboxylic acid
trans-4-aminomethylcyclohexane-1-carboxylic acid
trans-Amcha
trans-Tranexamic acid
trans-p-(Aminomethyl)cyclohexanecarboxylic acid
21
Myrrhapproved, NutraceuticalPhase 319000-45-7
Synonyms:
Bola resin
Commiphora molmol resin
Commiphora myrrha gum resin
Commiphora myrrha resin
Commiphora myrrha resin extract
Common myrrh
Hirabol myrrh
 
Mo yao
Moyao (commiphora molmol)
Moyao (commiphora myrrha)
Myrrh (commiphora molmol)
Myrrh (commiphora myrrha)
Myrrha
Myrrha (commiphora molmol)
Myrrha (commiphora myrrha)
22
Folic Acidapproved, nutraceutical, vet_approvedPhase 2, Phase 3427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
23Trace ElementsPhase 35802
24MicronutrientsPhase 35802
25VitaminsPhase 35095
26Folic Acid AntagonistsPhase 2, Phase 32200
27Renal AgentsPhase 2, Phase 3732
28VaccinesPhase 3, Phase 2, Phase 16428
29TriclabendazolePhase 32
30SulfalenePhase 2, Phase 380
31Vitamin B ComplexPhase 2, Phase 34229
32Fanasil, pyrimethamine drug combinationPhase 3, Phase 2120
33
PiperaquinePhase 31094085-31-85079497
Synonyms:
1,3-bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
4,4'-(propane-1,3-diyldipiperazine-4,1-diyl)bis(7-chloroquinoline)
4085-31-8
5-23-03-00072 (Beilstein Handbook Reference)
7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline
83764-65-2
AC1L3UA1
AC1Q3T7B
AR-1F7471
 
BRN 0905079
C29H32Cl2N6
CHEMBL303933
CID122262
FT-0082661
I06-1673
LS-142194
Piperaquinoline
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro- (9CI)
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-)
ST51053186
piperaquine
34CoagulantsPhase 31428
35HemostaticsPhase 31359
36Ferric CompoundsPhase 3184
37Antifibrinolytic AgentsPhase 3459
38HematinicsPhase 31630
39Folinic AcidNutraceuticalPhase 2, Phase 33150
40Iron SupplementNutraceuticalPhase 3175
41Vitamin B9NutraceuticalPhase 2, Phase 34279
42FolateNutraceuticalPhase 2, Phase 34279
43
MefloquineapprovedPhase 25653230-10-74046
Synonyms:
(+)-(11R,2'S)-erythro-Mefloquine
(+)-Mefloquine
(+)-Threo-Mefloquine
(-)-(11S,2'R)-erythro-Mefloquine
(-)-Mefloquine
(-)-Threo-Mefloquine
(DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol
(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol
49752-90-1
51688-68-7
51742-87-1
51744-84-4
51744-85-5
53230-10-7
68682-27-9
AB00052310
AC1L1HAJ
AC1L249S
AC1L9UO6
AC1MHD7J
AC1MHD7O
AC1Q4K1I
AR-1G4597
BIDD:GT0596
BIDD:PXR0166
BPBio1_000190
BRD-A89585551-003-03-4
BSPBio_000172
C07633
C17H16F6N2O
CAS-51773-92-3
CHEBI:151162
CHEBI:403542
CHEMBL411329
CHEMBL411685
CHEMBL411686
CHEMBL416956
CID3000506
CID3000516
CID4046
CID40692
CID456309
D04895
DB00358
DivK1c_000790
EINECS 256-468-3
Erthro-.alpha.-[2-piperidyl]-2,8-bis[trifluoromethyl]-4-quinolinemethanol
HMS1922C09
HMS502H12
HSDB 6853
IDI1_000790
KBio1_000790
KBio2_001792
KBio2_004360
KBio2_006928
KBio3_002046
KBioGR_001392
KBioSS_001792
LS-142023
 
LS-187797
Lariam
Lariam (Hydrochloride)
MQ
Mefloquin
Mefloquina
Mefloquina [INN-Spanish]
Mefloquine
Mefloquine (USAN/INN)
Mefloquine HCL
Mefloquine [USAN:INN:BAN]
Mefloquine aziridine
Mefloquinone
Mefloquinum
Mefloquinum [INN-Latin]
Mephloquine
MolPort-003-981-155
Méfloquine
NCGC00016864-01
NCGC00094994-01
NCGC00094994-02
NCGC00094994-03
NCGC00094994-04
NCGC00161831-01
NCGC00161831-02
NINDS_000790
NSC157387
Prestwick0_000126
Prestwick1_000126
Prestwick2_000126
Prestwick3_000126
RO 13-7224
RO 13-7225
RTI1169-1-1
RTI1172-1-1
RTI1173-1-1
RTI1174-1-1
RTI1188-1-1
RTI1189-1-1
Racemic mefloquine
Ro 21-5998
Ro 21-5998 (Hydrochloride)
Ro 215998
Ro-21-5998-001
SPB-80406
SPBio_001591
SPBio_002111
SPECTRUM1503070
Spectrum2_001516
Spectrum3_000953
Spectrum4_001066
Spectrum5_001122
Spectrum_001312
UNII-TML814419R
WR 142490
WR-142,490
WR-142490
WR-177,602
[(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol
[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol
alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol
mefloquine
nchembio.215-comp3
nchembio.87-comp20
44
Aluminum hydroxideapprovedPhase 120121645-51-2
Synonyms:
Al(OH)3
Aluminium hydroxide
Aluminium hydroxide gel, dried
 
Aluminium hydroxide, dried
Aluminum hydroxide gel, dried
Aluminum hydroxide, dried
Dried aluminium hydroxide
Dried aluminum hydroxide gel
45Anti-Ulcer AgentsPhase 11767
46AntibodiesPhase 16045
47ImmunoglobulinsPhase 16045
48Gastrointestinal AgentsPhase 18109
49Adjuvants, ImmunologicPhase 12484
50Aluminum sulfatePhase 187

Interventional clinical trials:

(show top 50)    (show all 56)
idNameStatusNCT IDPhase
1Artemisinin-based Combination Therapy-Intermittent Preventive Treatment (ACT-IPT) Trial Among Schoolchildren in Kassena-Nankana, GhanaUnknown statusNCT01459146Phase 4
2Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital ImmunologyCompletedNCT02878564Phase 4
3Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in BrazilCompletedNCT00403611Phase 4
4A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in ChildrenCompletedNCT01087099Phase 4
5Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in People With SchistosomiasisRecruitingNCT02734186Phase 4
6Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)Not yet recruitingNCT02868385Phase 4
7Safety and Efficacy of Mirazid for Schistosomiasis TreatmentCompletedNCT01529710Phase 3
8Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma HaematobiumCompletedNCT00870649Phase 3
9Schistosoma Haematobium Infections and PraziquantelCompletedNCT01558336Phase 3
10Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating SchistosomiasisCompletedNCT00510159Phase 2, Phase 3
11Impact IPT With Sulfadoxine-pyrimethamine or Sulfadoxine-pyrimethamine Plus Piperaquine in SchoolchildrenCompletedNCT01722539Phase 3
12IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in TanzaniaRecruitingNCT02541708Phase 3
13Haemorrhage Alleviation With Tranexamic Acid- Intestinal SystemRecruitingNCT01658124Phase 3
14Activity of Mefloquine Against Urinary SchistosomiasisCompletedNCT01132248Phase 2
15Schistosoma Mansoni Morbidity in Children Aged 1-5 YearsCompletedNCT01901484Phase 2
16S. Japonicum and Pregnancy OutcomesCompletedNCT00486863Phase 2
17Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African AdolescentsCompletedNCT02178748Phase 2
18An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni)RecruitingNCT02806232Phase 2
19Study to Evaluate the Safety of the Vaccine Prepared sm14 Against SchistosomiasisCompletedNCT01154049Phase 1
20Clinical Trial of Bilhvax,a Vaccine Candidate Against SchistosomiasisCompletedNCT01512277Phase 1
21Praziquantel-Pharmacokinetic StudyCompletedNCT01288872Phase 1
22Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDSCompletedNCT02376582Phase 1
23A Phase I Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel® With or Without GLA-AF for Intestinal Schistosomiasis in Healthy AdultsActive, not recruitingNCT02337855Phase 1
24Evaluation of Strategies for Improved Uptake of Preventive Treatment for Intestinal SchistosomiasisUnknown statusNCT01869465
25Antioxidant Supplements in the Reversal of Schistosomal Peri-portal FibrosisUnknown statusNCT01260012
26A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment OutcomesUnknown statusNCT01541631
27Health Benefits of Repeated Treatment in Pediatric SchistosomiasisCompletedNCT01424410
28Women and Children as the Focus for Control of Schistosomiasis Infections in the Irrigations Area of Burkina FasoCompletedNCT00463528
29Arachidonic Acid Treatment Against Schistosomiasis Infection in ChildrenCompletedNCT02144389
30Urinary Schistosomiasis InfectionCompletedNCT00138450
31Assessment of Anaemia Attributable to Schistosomiasis in School Children in Kenya: Mechanisms and Effect of TreatmentCompletedNCT00414479
32Schistosomiasis in Women of Reproductive Age in Burkina Faso: Implications for ControlCompletedNCT00463632
33Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in ZambiaCompletedNCT00276224
34Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control ProgrammesCompletedNCT00463593
35Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern GhanaCompletedNCT00463931
36Evaluation of the Use of a Urin Test Strip to Determine the Spread of Schistosoma Infections in Areas Where Schistosomiasis Infections Are Low in KenyaCompletedNCT00463307
37Urogenital Schistosomiasis and Sexually Transmitted Infections in MadagascarCompletedNCT00713999
38Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern SenegalCompletedNCT01553552
39Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or SurgeryCompletedNCT01931826
40The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, UgandaCompletedNCT00215267
41Safety and Efficacy of Drug Combinations Against SchistosomiasisCompletedNCT01050374
42Worm Infestation and Child Health in ZimbabweCompletedNCT01283165
43Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen RepertoiresCompletedNCT01214876
44Pulmonary Hypertension in Patients With Sickle Cell Disease in NigeriaCompletedNCT00367523
45Safety and Efficacy of Drug Combinations Against Triple InfectionsCompletedNCT01050517
46Community Directed Treatment of Soil-Transmitted Helminths Among Young Children in ZambiaCompletedNCT00349323
47Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, TanzaniaCompletedNCT00347113
48Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive DisordersCompletedNCT02105714
49Influence of Transmission Season on Outcome of Treatment of Schistosoma Haematobium Infection in MozambiqueCompletedNCT00231322
50HIV Accelerated Liver Disease in UgandaCompletedNCT01524562

Search NIH Clinical Center for Schistosomiasis

Inferred drug relations via UMLS67/NDF-RT45:

Genetic Tests for Schistosomiasis

About this section

Anatomical Context for Schistosomiasis

About this section

MalaCards organs/tissues related to Schistosomiasis:

35
Liver, Testes, Kidney, Skin, Spleen, Colon, T cells

Animal Models for Schistosomiasis or affiliated genes

About this section

MGI Mouse Phenotypes related to Schistosomiasis:

40 (show all 14)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107718.3CD40LG, F2, IFNG, IFNGR1, IL10, IL13
2MP:00053888.2F2, IFNG, IL10, IL13, IL2, IL4
3MP:00053818.2ALB, F2, IFNG, IFNGR1, IL10, IL13
4MP:00053678.2ALB, CD40LG, CD79A, IFNG, IFNGR1, IL4
5MP:00020068.2ALB, CD79A, IFNG, IFNGR1, IL10, IL2
6MP:00053798.1ALB, CD40LG, IFNG, IFNGR1, IL10, IL13
7MP:00053908.0CD40LG, F2, IFNG, IFNGR1, IL10, IL13
8MP:00053897.7CD40LG, F2, IFNG, IFNGR1, IL10, IL13
9MP:00053707.6ALB, IFNG, IFNGR1, IL10, IL2, IL4
10MP:00053847.2ALB, CD40LG, CD79A, IFNG, IFNGR1, IL10
11MP:00053787.2F2, FABP12, IFNG, IL10, IL13, IL2
12MP:00053976.9CD40LG, CD79A, F2, IFNG, IFNGR1, IL10
13MP:00053876.9CD40LG, CD79A, F2, IFNG, IFNGR1, IL10
14MP:00053766.2ALB, CD40LG, CD79A, F2, IFNG, IFNGR1

Publications for Schistosomiasis

About this section

Articles related to Schistosomiasis:

(show top 50)    (show all 1303)
idTitleAuthorsYear
1
Schistosomiasis therapeutics: whats in the pipeline? (26508363)
2015
2
Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals. (24402703)
2014
3
Colonic schistosomiasis and associated cecal neuroma. (23923251)
2013
4
Diagnosis and treatment of schistosomiasis in children in the era of intensified control. (24127662)
2013
5
Macrophage-derived Hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni. (23121638)
2013
6
Refolding of the recombinant protein Sm29, a step toward the production of the vaccine candidate against schistosomiasis. (24084635)
2013
7
Effect of school based treatment on the prevalence of schistosomiasis in endemic area in yemen. (23914234)
2013
8
New endemic foci of schistosomiasis infections in the Philippines. (23583862)
2013
9
Industrial Scale Isolation, Structural and Spectroscopic Characterization of Epiisopiloturine from Pilocarpus microphyllus Stapf Leaves: A Promising Alkaloid against Schistosomiasis. (23840522)
2013
10
Cytokine Pattern of T Lymphocytes in Acute Schistosomiasis mansoni Patients following Treated Praziquantel Therapy. (23401741)
2013
11
Neglected tropical diseases as a cause of chronic liver disease: the case of Schistosomiasis and Hepatitis C Co-infections in Egypt. (23295048)
2013
12
Community health workers' experiences and perspectives on mass drug administration for schistosomiasis control in western Kenya: the SCORE Project. (23091190)
2012
13
Prevalence of urinary schistosomiasis in school-aged children in Langai, Plateau State: pre- and post-intervention. (23311180)
2012
14
Correlation between acute schistosomiasis japonica and serum interleukin-33 levels]. (22590860)
2012
15
Evidence of intra-hepatic vascular proliferation remodeling early after cure in experimental schistosomiasis mansoni: an immunohistochemical descriptive study. (22019417)
2012
16
Brain magnetic resonance imaging findings in young patients with hepatosplenic schistosomiasis mansoni without overt symptoms. (22665605)
2012
17
Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. (22428079)
2012
18
A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasis. (23209848)
2012
19
Adjuvant selection for vaccination against murine schistosomiasis. (22882457)
2012
20
Improved mapping strategy to better inform policy on the control of schistosomiasis and soil-transmitted helminthiasis in Sierra Leone. (21645386)
2011
21
Schistosomiasis in Belgian military personnel returning from the Democratic Republic of Congo. (22165667)
2011
22
Clinical and haemodynamic evaluation of chronic thromboembolic pulmonary hypertension patients scheduled for pulmonary thromboendarterectomy: Is schistosomiasis hypertension an important confounding factor? (21243290)
2010
23
Intestinal schistosomiasis and soil-transmitted helminthiasis in Ugandan schoolchildren: a rapid mapping assessment. (19908189)
2009
24
Can coverage of schistosomiasis and soil transmitted helminthiasis control programmes targeting school-aged children be improved? New approaches. (19178756)
2009
25
Nigeria's war on terror: fighting dracunculiasis, onchocerciasis, lymphatic filariasis, and schistosomiasis at the grassroots. (19407107)
2009
26
Evaluation of circulating cathodic antigen (CCA) strip for diagnosis of urinary schistosomiasis in Hassoba school children, Afar, Ethiopia. (18416249)
2008
27
Cystoscopy in the diagnosis and follow-up of urinary schistosomiasis in Brazilian soldiers returning from Mozambique, Africa. (16547578)
2006
28
Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? (16380294)
2006
29
Microarray DNA chip in analyzing the association between HLA-DRB and advanced hepatosplenic schistosomiasis]. (16566202)
2005
30
Applicability of a monoclonal antibody-based dipstick in diagnosis of urinary schistosomiasis in the Central Region of Ghana. (15361112)
2004
31
Schistosomiasis: a critical review. (11148754)
2001
32
Recent urban growth and urinary schistosomiasis in Niamey, Niger. (10929143)
2000
33
Hepatic fibrosis due to fascioliasis and/or schistosomiasis in Abis 1 village, Egypt. (12197343)
2000
34
Urinary schistosomiasis among schoolchildren in Ibadan, an urban community in south-western Nigeria. (10320657)
1999
35
A school-based schistosomiasis and intestinal helminthiasis control programme in Nigeria: acceptability to community members. (9809919)
1998
36
Transmission of intestinal schistosomiasis in Addis Ababa, Ethiopia. (8997864)
1996
37
Urinary schistosomiasis in childhood. (8073544)
1994
38
Egg viability in urinary schistosomiasis. II. Simplifying modifications and standardization of new methods. (7681485)
1993
39
Molluscicidal trials and correlation between the presence of Tetrapleura tetraptera in an area and the absence of the intermediate hosts of schistosomiasis and fascioliasis in southwest Nigeria. (2255208)
1990
40
To wash or not to wash (Nytrel filters and urinary Schistosomiasis). (15463042)
1988
41
Urinalysis reagent strips in the screening of children for urinary schistosomiasis in the RSA. (3116682)
1987
42
Ultrasonographical aspects of urinary schistosomiasis: assessment of morphological lesions in the upper and lower urinary tract. (3085056)
1986
43
Effect of praziquantel on hematuria and proteinuria in urinary schistosomiasis. (3938926)
1985
44
Single dose oral treatment in urinary schistosomiasis: a double blind trial. (6401550)
1983
45
The effect of metrifonate on hookworm infections in Kenyan children treated for urinary schistosomiasis. A preliminary report. (6892236)
1982
46
Manifestations of urinary schistosomiasis in a British provincial city. (5162609)
1971
47
Steroid therapy in chronic urinary schistosomiasis (bilharziasis). (6050892)
1967
48
Urinary schistosomiasis. A case report. (5594207)
1967
49
The test of cure in urinary schistosomiasis. (13422576)
1957
50
Cross intradermal reactions of patients with paragonimiasis, clonorchiasis and schistosomiasis to different trematode antigens and their clinical significance. (13277038)
1955

Variations for Schistosomiasis

About this section

Expression for genes affiliated with Schistosomiasis

About this section
Search GEO for disease gene expression data for Schistosomiasis.

Pathways for genes affiliated with Schistosomiasis

About this section

Pathways related to Schistosomiasis according to GeneCards Suite gene sharing:

(show all 48)
idSuper pathwaysScoreTop Affiliating Genes
19.7IFNG, IL10, TNF
2
Show member pathways
9.7IFNG, IFNGR1, TNF
39.6IFNG, IL2, TNF
49.6IFNG, TGFB1, TNF
59.5IL13, IL4, IL5, TGFB1
6
Show member pathways
9.5IFNG, IFNGR1, IL4, TNF
79.5GAPDH, IL10, IL13, TNF
89.4IL4, STAT6, TGFB1
99.4IFNG, IL10, TGFB1, TNF
109.3IFNG, IFNGR1, TGFB1, TNF
119.3IFNG, IFNGR1, TGFB1, TNF
129.3IFNG, IL13, IL2, TGFB1
139.3IFNG, IL13, IL2, IL4, IL5
149.3CD40LG, IFNG, IL2, IL4, IL5
15
Show member pathways
9.2IFNG, IL2, IL4, STAT6
16
Show member pathways
9.2IFNG, IFNGR1, IL2, IL4, TNF
179.1CD40LG, IFNG, IL10, TGFB1, TNF
189.1IFNG, IFNGR1, IL10, TGFB1, TNF
199.1IFNG, IL10, IL13, IL2, IL4, IL5
209.0IFNG, IL2, IL4, TGFB1, TNF
219.0IFNG, IL10, IL2, TGFB1, TNF
22
Show member pathways
9.0IFNG, IL10, IL2, TGFB1, TNF
23
Show member pathways
9.0CD40LG, IFNG, IL2, IL4, IL5, TNF
249.0CD40LG, IL10, IL4, IL5, TGFB1, TNF
25
Show member pathways
8.9IFNG, IFNGR1, IL13, IL2, IL4, TNF
268.9IFNG, IFNGR1, IL10, IL2, STAT6
278.8CD40LG, IL10, IL13, IL2, IL4, IL5
28
Show member pathways
8.8IFNG, IL10, IL13, IL2, IL4, IL5
298.8IFNG, IL10, IL13, IL2, IL4, IL5
30
Show member pathways
8.8IFNG, IFNGR1, IL10, IL2, TGFB1, TNF
318.7CD79A, IFNG, IL10, IL2, IL4, IL5
32
Show member pathways
8.7CD40LG, IFNG, IFNGR1, IL10, IL4, TGFB1
338.6IFNG, IL10, IL13, IL2, IL4, IL5
34
Show member pathways
8.5IFNG, IFNGR1, IL10, IL13, IL2, IL4
35
Show member pathways
8.5CD79A, IGHE, IL13, IL4, IL5, TNF
36
Show member pathways
8.4CD40LG, IL10, IL13, IL2, IL4, IL5
378.4IFNG, IL10, IL13, IL2, IL4, IL5
38
Show member pathways
8.4F2, IFNG, IL10, IL2, STAT6, TNF
398.3CD40LG, IGHE, IL10, IL4, IL5, STAT6
40
Show member pathways
8.2IFNG, IFNGR1, IL10, IL2, STAT6, TGFB1
418.2CD40LG, CD79A, IFNG, IL10, IL2, IL4
42
Show member pathways
8.1CD40LG, CD79A, IFNG, IL10, IL2, IL4
43
Show member pathways
7.9CD40LG, IL10, IL13, IL2, IL4, IL5
44
Show member pathways
7.6CD40LG, CD79A, IFNG, IFNGR1, IGHE, IL10
45
Show member pathways
7.5CD40LG, F2, IFNG, IFNGR1, IL10, IL13
46
Show member pathways
7.2F2, IFNG, IFNGR1, IL10, IL13, IL2
47
Show member pathways
6.6CD40LG, IFNG, IFNGR1, IL10, IL13, IL2
48
Show member pathways
6.5CD40LG, CD79A, IFNG, IFNGR1, IGHE, IL13

GO Terms for genes affiliated with Schistosomiasis

About this section

Cellular components related to Schistosomiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1platelet alpha granule lumenGO:003109310.0ALB, SERPINF2, TGFB1
2external side of plasma membraneGO:00098978.4CD40LG, CD79A, IFNG, IGHE, IL13, IL4
3blood microparticleGO:00725628.1ALB, F2, IGHE, SERPINF2, TGFB1
4extracellular spaceGO:00056156.5ALB, CD40LG, F2, IFNG, IL10, IL13
5extracellular regionGO:00055766.5ALB, F2, IFNG, IGHE, IL13, IL2

Biological processes related to Schistosomiasis according to GeneCards Suite gene sharing:

(show all 43)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of complement-dependent cytotoxicityGO:190366010.8IL13, IL4
2regulation of isotype switchingGO:004519110.8IL10, IL4
3regulation of proton transportGO:001015510.8IL13, IL4
4positive regulation of mast cell degranulationGO:004330610.8IL13, IL4
5type 2 immune responseGO:004209210.8IL10, IL4
6positive regulation of immunoglobulin productionGO:000263910.7IL13, IL4
7receptor biosynthetic processGO:003280010.7IL10, TNF
8negative regulation of cytokine secretion involved in immune responseGO:000274010.7IL10, TNF
9positive regulation of vitamin D biosynthetic processGO:006055710.6IFNG, TNF
10positive regulation of calcidiol 1-monooxygenase activityGO:006055910.6IFNG, TNF
11positive regulation of immunoglobulin secretionGO:005102410.6IL2, IL5
12regulation of immunoglobulin secretionGO:005102310.6CD40LG, TNF
13negative regulation of interleukin-17 productionGO:003270010.6IFNG, TGFB1
14positive regulation of podosome assemblyGO:007180310.6IL5, TNF
15negative regulation of endothelial cell apoptotic processGO:200035210.5IL10, IL13, IL4
16T-helper 1 cell lineage commitmentGO:000229610.5IL4, STAT6
17positive regulation of MHC class II biosynthetic processGO:004534810.5IFNG, IL10, IL4
18defense response to protozoanGO:004283210.5IFNG, IL10, IL4
19positive regulation of chemokine biosynthetic processGO:004508010.4IFNG, IL4, TNF
20positive regulation of regulatory T cell differentiationGO:004559110.4IL2, TGFB1
21positive regulation of isotype switching to IgE isotypesGO:004829510.4IL4, STAT6
22positive regulation of isotype switching to IgG isotypesGO:004830410.4IFNG, IL2, IL4
23B cell proliferationGO:004210010.3CD40LG, CD79A, IL10
24positive regulation of mononuclear cell migrationGO:007167710.3IL4, TGFB1, TNF
25negative regulation of fibrinolysisGO:005191810.3F2, SERPINF2
26negative regulation of growth of symbiont in hostGO:004413010.3IFNG, IL10, TNF
27positive regulation of smooth muscle cell proliferationGO:004866110.2IL13, SERPINF2, TNF
28protein import into nucleus, translocationGO:000006010.2IFNG, TGFB1, TNF
29extrinsic apoptotic signaling pathwayGO:009719110.2IFNG, TGFB1, TNF
30positive regulation of B cell proliferationGO:003089010.1IL13, IL2, IL4, IL5
31B cell differentiationGO:003018310.1CD40LG, CD79A, IL10, IL4
32positive regulation of sequence-specific DNA binding transcription factor activityGO:005109110.0IL10, IL4, IL5, TNF
33positive regulation of collagen biosynthetic processGO:00329679.9F2, SERPINF2, TGFB1
34positive regulation of T cell proliferationGO:00421029.8CD40LG, IFNG, IL2, IL4
35response to inactivityGO:00148549.8F2, IL10
36positive regulation of protein phosphorylationGO:00019349.3F2, IL2, IL4, TGFB1, TNF
37defense response to bacteriumGO:00427429.3IFNG, IGHE, IL10, TNF
38inflammatory responseGO:00069549.3CD40LG, IL10, IL13, IL5, TGFB1, TNF
39positive regulation of transcription, DNA-templatedGO:00458939.2IFNG, IL10, IL4, IL5, TGFB1, TNF
40response to organic substanceGO:00100339.2ALB, IL10, SERPINF2, TGFB1, TNF
41immune responseGO:00069558.7IGHE, IL10, IL13, IL2, IL4, IL5
42positive regulation of cell proliferationGO:00082848.4F2, IFNG, IL2, IL4, IL5, TGFB1
43positive regulation of transcription from RNA polymerase II promoterGO:00459448.0IFNG, IL10, IL2, IL4, SERPINF2, STAT6

Molecular functions related to Schistosomiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1growth factor activityGO:00080838.7F2, IL10, IL2, IL4, IL5, TGFB1
2cytokine activityGO:00051257.9CD40LG, IFNG, IL10, IL13, IL2, IL4

Sources for Schistosomiasis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet